Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

World Oncology Forum 2015 /
The knock-on effects of breast cancer drugs

22nd - 24th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.12.15
Views: 1713

Prof V Craig Jordan - University of Texas MD Anderson Cancer Center, Houston, USA

Prof Jordan talks to ecancertv at the World Oncology Forum 2015 about how tamoxifen - a drug originally developed as a contraceptive - has gone on to become an effective breast cancer drug.

However, he argues that tamoxifen isn't worth taking as a preventive measure against breast cancer and that we need 'smarter' medicine.

He explains how many drugs effective in treating breast cancer have other effects on the body which can be good or bad depending on the individual. He explains the undesirable impacts of some drugs which helped against breast cancer but contributed to endometrial cancer.

On the other hand, some breast cancer drugs, such as lasofoxifene (which he describes as a "miracle of molecular biology"), can prevent stroke, osteoporosis and heart disease.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation